Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMED10P2 is a processed pseudogene, meaning it is a non-functional copy of the TMED10 gene within the human genome. Unlike its parental gene TMED10, which encodes a p24 family protein involved in vesicular protein trafficking, TMED10P2 does not code for a functional protein. Recent studies show that some pseudogenes, including TMED10P2, can be transcribed and their RNAs may play regulatory roles, such as acting as miRNA sponges or being involved in gene expression modulation. TMED10P2 has been identified as a downregulated retrocopy in lung cancers, indicating potential as a tumor biomarker in research. However, there is no evidence of direct protein-coding function, established biological role, or druggability.
None established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane p24 trafficking protein 10 pseudogene 2 (TMED10P2).